Orphazyme A/S (NASDAQ:ORPH) went up by 301.53% from its latest closing price compared to the recent 1-year high of $14.78. The company’s stock price has collected 320.00% of gains in the last five trading sessions.
Is It Worth Investing in Orphazyme A/S (NASDAQ :ORPH) Right Now?
Opinions of the stock are interesting as 2 analysts out of 4 who provided ratings for Orphazyme A/S declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $10.81. ORPH currently public float of 24.59M and currently shorts hold a 0.14% ratio of that float. Today, the average trading volume of ORPH was 61.35K shares.
ORPH’s Market Performance
ORPH stocks went up by 320.00% for the week, with a monthly jump of 254.73% and a quarterly performance of 62.92%. The volatility ratio for the week stands at 297.18% while the volatility levels for the past 30 days are set at 74.74% for Orphazyme A/S. The simple moving average for the period of the last 20 days is 284.87% for ORPH stocks with a simple moving average of 106.05% for the last 200 days.
Analysts’ Opinion of ORPH
Many brokerage firms have already submitted their reports for ORPH stocks, with BofA Securities repeating the rating for ORPH by listing it as a “Underperform.” The predicted price for ORPH in the upcoming period, according to BofA Securities is $5 based on the research report published on March 30th of the current year 2021.
Guggenheim, on the other hand, stated in their research note that they expect to see ORPH reach a price target of $27. The rating they have provided for ORPH stocks is “Buy” according to the report published on October 26th, 2020.
BofA Securities gave a rating of “Buy” to ORPH, setting the target price at $13 in the report published on October 26th of the previous year.
ORPH Trading at 178.24% from the 50-Day Moving Average
After a stumble in the market that brought ORPH to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 42.08% of gains for the given period.
Volatility was left at 74.74%, however, over the last 30 days, the volatility rate increased by 297.18%, as shares surge +284.62% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +126.29% upper at present.
During the last 5 trading sessions, ORPH rose by +320.00%, in comparison to the 20-day moving average, which settled at $6.23. In addition, Orphazyme A/S saw 95.71% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ORPH
The total capital return value is set at -148.19, while invested capital returns managed to touch -164.77.
Based on Orphazyme A/S (ORPH), the company’s capital structure generated 11.40 points at debt to equity in total, while total debt to capital is 10.23. Total debt to assets is 8.60, with long-term debt to equity ratio resting at 5.43. Finally, the long-term debt to capital ratio is 4.88.
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.70.